Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 1

2(40.0%)

N/A

1(20.0%)

5Total

Phase 2(2)

Phase 1(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03745183Not ApplicableCompleted

Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata

Role: lead

NCT01885611Phase 1Withdrawn

Virgin Coconut Oil Oral Supplementation for Leprosy Patients

Role: lead

NCT02432040Phase 2Completed

Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

Role: lead

NCT01943136Phase 1Unknown

The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

Role: lead

NCT01783353Phase 2Completed

Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial

Role: lead

NCT01465061Completed

A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis

Role: collaborator

All 6 trials loaded